Although SHBG was not associated with overall risk of ovarian cancer in one recent study [44], both LCAT and SHBG downregulation have been reported to provide important information on the aggressiveness of the ovarian cancer [45]. The gene discussed is SHBG; the disease is ovarian carcinoma.